Shares of Adamis Pharmaceuticals Corp. (NASDAQ:ADMP) shot up 11.5% on Tuesday . The company traded as high as $3.00 and last traded at $3.00, with a volume of 1,110,579 shares traded. The stock had previously closed at $2.69.

Separately, Maxim Group reduced their target price on Adamis Pharmaceuticals Corp. from $17.00 to $10.00 and set a “buy” rating for the company in a research note on Thursday, July 21st.

The stock’s market capitalization is $57.44 million. The company’s 50 day moving average is $2.87 and its 200 day moving average is $5.27.

Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.